ERMA — Enorama Pharma AB Share News
0.000.00%
- SEK88.39m
- SEK86.29m
- SEK2.74m
Brief: Enorama Pharma Q4 Operating Loss Widens To SEK 8.7 Mln
Brief: Enorama Pharma Enters Loan Agreement Of SEK 8 Mln With DS Global Pte. Limited
Brief: Enorama Pharma Q3 Oper Loss Narrows To SEK 4.8 Mln
Brief: Enorama Pharma Carries Out Directed Issue Of Units
Brief: Enorama Pharma Enters Loan Deal With Nordea Bank
Brief: Enorama Pharma Q2 Oper Loss Narrows To SEK 1.8 Mln
Brief: Enorama Pharma Gets Objection To Swedish Patent
Brief: Enorama Pharma Enters Deal With Twinroll Service
Brief: Enorama Pharma Q1 Operating Loss Flat At SEK 4.4 Mln
Brief: Enorama Pharma Q4 Oper Loss Widens To SEK 7.0 Million
Brief: Enorama Pharma Secures Financing Through Loan Agreement Of SEK 17 Mln
Brief: Enorama Pharma Gets Order Worth About SEK 1.9 Million
Brief: Enorama Pharma Gets Order In US Worth SEK 1.1 Mln
Brief: Enorama Pharma Q3 Operating Loss Widens To SEK 7.5 Mln
Brief: Enorama Pharma Applies For Patent
Brief: Enorama Pharma Enters Into Term-Sheet Agreement With Arzneimittel GmbH
Brief: Enorama Pharma Files Patent Application In Sweden
Brief: Enorama Pharma Carries Out Directed Issue Of About SEK 15 Million
Brief: Enorama Pharma Q2 Operating Loss Widens To SEK 4.0 Million